NCT00047567View on ClinicalTrials.gov

Open-label Adjunctive Zonisamide for Bipolar Disorder

PHASE4TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Bipolar Disorders
Interventions
DRUG

zonisamide

Sponsors
All Listed Sponsors
lead

Elan Pharmaceuticals

INDUSTRY

NCT00047567 - Open-label Adjunctive Zonisamide for Bipolar Disorder | Biotech Hunter | Biotech Hunter